Lurasidone Hydrochloride Tablet, Coated
Product Images NDC 65162-879

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 65162-879). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 (Lurasidone HCl Tablets 1)

Chemical structure of Lurasidone Hydrochloride, showing the molecular configuration with multiple ring systems including a bicyclic structure, piperazine ring, and a heterocyclic thiazole group, along with the hydrochloride component.*

FDA Label Image

1 (Lurasidone HCl Tablets 2)

A plot showing the impact of various interacting drugs on the pharmacokinetics of Lurasidone, specifically the fold change and 90% confidence intervals for Cmax and AUC relative to Lurasidone alone. It categorizes drugs as strong CYP3A4 inhibitors, moderate CYP3A4 inhibitors, and strong CYP3A4 inducers, listing Ketoconazole, Diltiazem, Rifampin, and Lithium with corresponding changes in Lurasidone levels.*

FDA Label Image

2 (Lurasidone HCl Tablets 3)

A pharmacokinetic chart illustrating fold change and 90% confidence intervals in Cmax, AUC, and trough levels of various interacting drugs relative to the drug alone. It shows data for P-gp substrates Digoxin, CYP3A4 substrate Midazolam, oral contraceptives Ethinyl Estradiol and Norelgstromin, and Lithium. The x-axis represents change relative to interactive drug alone, ranging from -1.0 to 1.0.*

FDA Label Image

3 (Lurasidone HCl Tablets 4)

A pharmacokinetic chart showing fold change and 90% confidence intervals for Cmax and AUC values relative to reference. It includes data categories for renal impairment (mild, moderate, severe), hepatic impairment (mild, moderate, severe), and population descriptions by gender and race (Asian), plotted on an x-axis labeled 'Change relative to reference.'*

FDA Label Image

20 (Lurasidone HCl Tablets 5)

Label for Lurasidone Hydrochloride Tablets 20 mg by Amneal Pharmaceuticals LLC. The coated oral tablets come in a 30-count package. The label includes dosage and storage instructions, contact information for the manufacturer and distributor, and a barcode with an adjacent QR code.*

FDA Label Image

40 (Lurasidone HCl Tablets 6)

Lurasidone Hydrochloride Tablets 40 mg coated tablets label showing 30 tablets in the package. Label indicates prescription use only and instructs pharmacists to dispense the Medication Guide to each patient. Manufactured by Amneal Pharmaceuticals Pvt. Ltd. in India, distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. Includes storage instructions, printed NDC number 65162-880-03, barcode, and a QR code for the medication guide.*

FDA Label Image

60 (Lurasidone HCl Tablets 7)

Label for Lurasidone Hydrochloride Tablets 60 mg, coated oral tablets. The label includes the NDC 65162-082, states Rx only, and contains 30 tablets. It shows Amneal Pharmaceuticals LLC as the labeler and manufacturer. The label also provides storage instructions and a QR code for the medication guide.*

FDA Label Image

80 (Lurasidone HCl Tablets 8)

Lurasidone Hydrochloride Tablets 80 mg coated tablets, packaged in a bottle of 30 tablets. The label includes dosing and storage instructions, a QR code linking to a medication guide, and is manufactured and distributed by Amneal Pharmaceuticals LLC. The label also features a pink section with the Amneal logo.*

FDA Label Image

120 (Lurasidone HCl Tablets 9)

Label of Lurasidone Hydrochloride Tablets 120 mg by Amneal Pharmaceuticals LLC. The label states 30 tablets, coated oral dosage form. It includes usage instructions with storage conditions between 15 to 30°C, and references a medication guide URL. Manufacturer and distributor details are Amneal Pharmaceuticals Pvt. Ltd., India and Amneal Pharmaceuticals LLC, Bridgewater, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.